United States

Koninklijke Philips NV (PHG.AS)

PHG.AS on Amsterdam Stock Exchange

11:35am EST
Change (% chg)

€0.05 (+0.18%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for PHG.AS


Koninklijke Philips N.V. is a health and well-being company. The Company operates through three segments: Healthcare, Consumer Lifestyle and Lighting. Its Healthcare segment consists of imaging systems, healthcare informatics, services and solutions, patient care and monitoring solutions, and customer services. Its Consumer... (more)


Beta: 1.42
Market Cap(Mil.): €26,090.48
Shares Outstanding(Mil.): 929.65
Dividend: 0.80
Yield (%): 2.85


  PHG.AS Industry Sector
P/E (TTM): 68.80 52.89 29.35
EPS (TTM): 0.41 -- --
ROI: 1.90 7.57 12.97
ROE: 3.28 11.40 14.11

Philips upbeat on prospects for new image-guided therapy platform

(This version of the story has been refiled to remove extraneous word from headline)

2:07pm EST

REFILE-Philips upbeat on prospects for new image-guided therapy platform

AMSTERDAM, Feb 22 Philips on Wednesday announced the introduction of a new platform for image guided therapy which enables doctors to combine the use of several medical scanners, imaging data and large screen displays as they perform minimally-invasive surgeries.

2:03pm EST

BRIEF-Philips Lighting intends to repurchase 3.5 mln shares from Royal Philips

* Philips lighting intends to repurchase 3.5 million shares from Royal Philips

Feb 08 2017

Philips misses fourth-quarter forecasts, discloses US defibrillator dispute

AMSTERDAM Medical equipment maker Philips missed forecasts for fourth-quarter earnings on Tuesday and disclosed a dispute with the U.S. Justice Department over heart defibrillators it had sold until 2016, but said the matter would not alter its medium term outlook.

Jan 24 2017

UPDATE 3-Philips misses Q4 forecasts, discloses US defibrillator dispute

* Shares down 2.8 pct (Updates after press conference; Removes background material on 2012 defibrillator recall as incidents are not related; raises paragraphs on earnings, adds analyst comment; adds that shares have regained some losses.)

Jan 24 2017

Philips discloses conflict with US over defibrillators along with Q4 earnings

AMSTERDAM, Jan 24 Medical equipment maker Philips on Tuesday disclosed a conflict with the U.S. government over defibrillators it sold prior to 2015, along with fourth quarter earnings in which it missed analysts' estimates.

Jan 24 2017

BRIEF-Koninklijke Philips Q4 sales up at 7.2 billion euros

* Q4 sales 7.2 billion euros ($7.74 billion) versus 7.30 billion euros in Reuters poll

Jan 24 2017

BRIEF-Koninklijke Philips and Banner Health sign 15-year agreement

* And Banner Health sign 15-year agreement to extend successful connected healthcare programs, transforming care and lowering costs, while improving quality Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jan 23 2017

Philips to sell Lumileds stake to U.S. investor Apollo for $1.5 billion

AMSTERDAM Philips will sell an 80.1 percent stake in Lumileds, its LED components and car lighting business, to U.S. investor Apollo, receiving $1.5 billion in cash, it said on Monday.

Dec 12 2016

Factbox: Deals scuppered by U.S. regulatory scrutiny

Aixtron SE's takeover by China's Fujian Grand Chip Investment Fund may soon be on the list of deals called off due to increased U.S. regulatory scrutiny.

Dec 02 2016

More From Around the Web

Earnings vs. Estimates